Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy targetKamal Mandal, Arun P. Wiita, Gianina Wicaksono et al.|Nature Cancer|2023Cited by 39
Structural Surfaceomics Reveals an AML-Specific Conformation of Integrin-β2 As an Immunotherapeutic TargetKamal Mandal, Arun P. Wiita, Gianina Wicaksono et al.|Blood|2022Cited by 4
Structural surfaceomics reveals an AML-specific conformation of Integrin-β2 as a CAR-T therapy targetKamal Mandal, Arun P. Wiita, Gianina Wicaksono et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 2
Abstract 4820: Anti-CD72 nanobody-based CAR-T affinity maturation leads to improved in vitro efficacy versus low antigen density lymphoma models, but limited benefit in vivoAdila Izgutdina, Arun P. Wiita, Tasfia Rashid et al.|Cancer Research|2025Cited by 1
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesAdila Izgutdina, Arun P. Wiita, Szu-Ying Chen et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1